Costa rica launches study to map skin cancer patterns
NCT ID NCT07538960
First seen Apr 24, 2026 · Last updated Jun 13, 2026 · Updated 11 times
Summary
This study looks back at medical records of 350 adults with cutaneous T-cell lymphoma, a rare skin cancer, treated at Hospital México in Costa Rica between 2019 and 2025. Researchers aim to describe patient characteristics, treatments, and outcomes. No new treatments are tested; the goal is to gather information to improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital México
San José, Uruca, 10107, Costa Rica
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.